Allient (ALNT) Stock May Be Fully Priced As Cash Flow Falls Short
Allient stock has returned about 180% over the past five years. Yet at around US$89.97 per share, both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks currently point to the shares trading at a premium rather than as an obvious bargain.
- Over five years, a roughly 180% share price gain suggests early investors have already seen strong compounding. This can limit the margin of safety for anyone considering the stock today.
- Future cash flow growth and the company’s ability to convert earnings into reliable free cash flow may support today’s price. Any disappointment in execution or a need for heavier investment could weigh on what is already an expensive-looking valuation.
- Allient currently passes 0 of 6 valuation checks. This means the broader assessment leans expensive rather than pointing to a clear value opportunity, according to our 0/6 value score.
The issue now is whether Allient’s recent share price level already reflects its longer term cash flow potential, or if the current premium still leaves enough upside to justify the risk.
Does Allient Look Pricey on Cash Flow?
The Discounted Cash Flow (DCF) model here estimates what Allient might be worth based on projected future cash the business could return to shareholders. Allient generated around $39.82 million of free cash flow over the latest twelve months, and the model assumes those cash flows continue growing rather than shrinking, using a 2 Stage Free Cash Flow to Equity approach.
Under these assumptions, the DCF points to an intrinsic value of about $68.72 per share, compared with a current share price close to $89.97. That implies the stock trades at a premium of roughly 30.9% to this cash flow based estimate, suggesting the market is paying more for Allient than this model supports today.
On this DCF view, Allient stock appears overvalued relative to its projected cash flows and current price level.
Our Discounted Cash Flow (DCF) analysis suggests Allient may be overvalued by 30.9%. Discover 50 high quality undervalued stocks or create your own screener to find better value opportunities.
Does Allient Look Pricey on Earnings?
The P/E ratio is a useful way to see what you are paying for each dollar of Allient’s earnings. At around 64.2x, Allient’s current P/E sits well above the Electrical industry average of about 37.4x and the peer group average of roughly 34.9x, which already reflects a fair amount of optimism versus sector peers.
A more tailored fair P/E ratio for Allient, which considers its size, industry, margins and risk profile, is estimated at about 28.9x. Compared with the current 64.2x, this indicates the stock trades at a sizeable premium to what this framework would typically support, and the gap shows investors are currently paying a high price for each dollar of earnings relative to these benchmarks.
On this P/E view, Allient stock appears overvalued, with the market pricing its earnings well above the level implied by the fair multiple and sector averages.
See what the numbers say about this price — find out in our valuation breakdown.
The Allient Narrative: What Would Justify Today's Price?
Simply Wall St Narratives take the valuation puzzle around Allient and explain which assumptions about the company’s growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price, based on scenarios shared on the Community page. Each Narrative links a specific fair value to a particular storyline about Allient’s potential catalysts and risks, so you can assess over time which version of events seems to be unfolding.
One of the top community narratives on Allient: 22% overvalued
"Expectations for margin and earnings improvement could face headwinds from rising compliance costs, supply chain risks, and challenges in executing profitable expansion strategies..."
Read one of the top narratives on Allient
Do you think there's more to the story for Allient? Head over to our Community to see what others are saying!
The Bottom Line
Both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples point to Allient stock screening as overvalued, with the broader 0/6 value checks reinforcing that message. For you as a potential or existing shareholder, the debate now hinges less on spotting a mispricing and more on whether Allient can deliver the cash flow growth and margin improvement that today’s premium already anticipates. The key question is whether execution and capital allocation will be strong enough to sustain that optimism, or whether a cooler set of expectations eventually forces the valuation closer to more conservative assumptions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com